|
Medical Device Sector Pleads Govt To Implement MoH
Certification For Its Products The medical device sector
wants the Ministry of Heath and Family Welfare to implement the Ministry of
Health certification (MoH) in the country soon. The industry is hopeful that
this certification will give lot of credibility to the industry both within the
country and outside. According to Dr K K Menon, founder
chairman and managing director, Maestros Mediline Systems, “Having an effective
MoH certification will help in boosting the market of the products that is being
sold in the India. Moreover, if these products are duly registered with the
government it will not only authenticate the quality of the products but will
also improve the service to the doctors and patients. "He
further stressed that though the government is taking steps for the industry by
coming up with new regulations it should be more prompt in the implementation of
the same if they want to see the desired effect. ”It is high
time for the government to implement MoH certification and make it compulsory,
as it will ensure that every company will follow correct regulations and quality
systems as required. As of now there are many unauthorised and unorganised
companies in this sector that is impaling the growth of our industry and thus to
keep a tab on them this step has to be taken,” Dr Menon added.
He informed that as of today there is no regulation in the country for the
medical device sector which has a huge growth potential in the country. This
lack of regulation has made the sector vulnerable for anything and everything.
An industry insider points out that there are many companies in India who import
cheap and low quality products from abroad and sell them to the doctors in
India. This is not only dangerous for the patients but is also affecting the
development of the sector. Industry believes that MoH
certification can help in checking these undesirable practices of these
companies besides bringing the medical device sector under the scrutiny of the
government. (Ref::
http://www.pharmabiz.com/NewsDetails.aspx?aid=64813&sid=1)
Bayer Healthcare To Acquire Pathway Medical Technologies
Bayer HealthCare announced that its affiliate, MEDRAD, Inc. has acquired Pathway
Medical Technologies, Inc., of Kirkland, Washington. Financial terms of the
agreement were not disclosed. With this acquisition, Bayer HealthCare is
strengthening its MEDRAD Interventional business by expanding its presence in
the field of vascular intervention technologies. Pathway
Medical Technologies is a leader in mechanical atherectomy in the field of
vascular intervention. The company’s products clear out blockages in the leg,
also known as Peripheral Arterial Disease or PAD. Pathway’s Jetstream devices,
for example, allow for a minimally invasive procedure designed to restore
circulation in the peripheral arteries by reducing vascular narrowing caused by
plaque. With differential cutting, Jetstream products are designed to remove
plaque without harming healthy tissue. For the more than 12 million people alone
in the US estimated to have some form of PAD, Pathway products offer minimally
invasive treatment options to remove calcified and fibrotic plaque and restore
circulation in the peripheral arteries. ”The combination of
MEDRAD and Pathway Medical Technologies underscores our strategic commitment to
the treatment of patients in the growing interventional field,” said Dr. Jörg
Reinhardt, chairman of the board of management of Bayer HealthCare.
Pathway Medical Technologies, Inc. was founded to design, market and manufacture
medical devices for the treatment of vascular disease. The company’s initial
focus is treating peripheral arterial disease (PAD) more quickly and effectively
than existing technologies. An estimated 12 million people are afflicted by PAD
in the US and that number is projected to grow to over 20 million during the
next 10 years. The company’s Jetstream device allows for a minimally invasive
procedure designed to restore circulation in the peripheral arteries by removing
both hard and soft diseased tissue. The Bayer Group is a
global enterprise with core competencies in the fields of health care, nutrition
and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual
sales of EUR 16.9 billion (2010), is one of the world’s leading, innovative
companies in the healthcare and medical products industry and is based in
Leverkusen, Germany. (Ref:
http://www.pharmabiz.com/NewsDetails.aspx?aid=64825&sid=2) |
